Blog · Evidence, in plain language

Sleep medicine, CBT-I, or both? The 2026 answer.

Patients in medication care ask a practical question: if a sleep medicine helps, why add a therapy program, and if the therapy works, why keep the medicine? In 2026 the American Academy of Sleep Medicine published the first guideline built to answer exactly that comparison. Its answer is ordered, qualified, and worth knowing before your next follow-up.

By Karel Winner, DNP, PMHNP-BC · Published October 13, 2026

The question the guideline was built to answer

Chronic insomnia disorder affects roughly 10 to 15 percent of adults, according to the guideline. Earlier guidance treated the two main options separately: a 2017 guideline covered insomnia medicines, and a 2021 guideline covered behavioral treatments and gave multicomponent CBT-I, short for cognitive behavioral therapy for insomnia, a strong recommendation. Neither one answered what happens when both start at the same time, which is how many patients are actually treated. The 2026 guideline defines combination treatment that way, as CBT-I started alongside medication, and compares it against each treatment on its own.

The order the evidence produced

Read as a ranking, the guideline puts CBT-I alone first, combination treatment second, and medication alone last. It suggests combination treatment over medication alone, because the combination produced clinically meaningful gains in overall insomnia severity and in sleep continuity, meaning how sleep holds together across the night. It suggests against combination treatment over CBT-I alone, because adding medication did not produce clinically meaningful gains in severity, continuity, or daytime symptoms for most patients. Both recommendations are conditional, and both rest on evidence the guideline rates as low certainty. Conditional means the right choice can differ between patients, and the guideline expects clinicians to weigh what each patient values.

What the trials behind it looked like

Each comparison rested on six randomized trials reported in seven articles. In the trials against medication alone, most delivered CBT-I in person, and the combination group reported a little more morning sleepiness, an effect the panel judged minimal. Daytime results favored the combination but not by an amount the panel counted as clinically meaningful, and total sleep time did not meaningfully improve either, with the estimate slightly favoring medication alone. Against CBT-I alone, total sleep time did improve with the combination by an amount the panel counted as meaningful, although the confidence interval included zero, which is one reason the certainty rating stayed low.

The exception the guideline writes in itself

The guideline adds a remark that matters in a medication practice. Patients who place a higher value on getting more total sleep early in treatment, or a lower value on improving daytime symptoms, may reasonably choose the combination over CBT-I alone. In plain terms, the ranking is a starting point for a conversation, not a rule that overrides what a patient is trying to fix first. The guideline also notes that it studied treatments started together. The more common real world pattern, adding one treatment later when the first is not enough, was barely studied, so the panel made no recommendation about sequencing.

What this means at a medication visit

For a patient already taking a sleep medicine, this guideline is not an instruction to drop it. It is evidence that the behavioral half of treatment carries real weight, and that a medicine working alone is the weakest of the three arrangements studied. The useful questions for a follow-up are concrete: is the current medicine still earning its place, has a structured CBT-I program been tried or offered, and what would success look like in the first weeks, total sleep, steadier sleep, or better days. A prescriber who knows your full medication list and history can place those answers in order. A headline cannot.

The bottom line

The best current guidance says CBT-I on its own is the most effective first treatment for chronic insomnia, that adding it to medication beats medication on its own, and that adding medication to CBT-I helps most patients little, apart from possibly more total sleep early on. All of that comes with low certainty, stated by the panel itself. Held at that size, it is a strong reason to treat the therapy program as treatment, not as homework next to the real treatment.

Sources

This post is based on the sources below. The numbers and ratings quoted are the guideline's own.

Buysse and colleagues, Journal of Clinical Sleep Medicine (2026): the American Academy of Sleep Medicine clinical practice guideline on combination treatment for chronic insomnia disorder in adults, based on a systematic review using the GRADE process, with the evidence search completed in June 2025. Journal of Clinical Sleep Medicine.

American Academy of Sleep Medicine (2026): the guideline at a glance summary, listing both recommendations and the exception the guideline itself sets out for patients who value more total sleep early in treatment. AASM guideline at a glance.

Edinger and colleagues, Journal of Clinical Sleep Medicine (2021): the earlier AASM guideline on behavioral and psychological treatments for chronic insomnia, which gave multicomponent CBT-I its strong recommendation. PubMed record.

Please read this part

Nothing here is medical advice, and reading it does not create a treatment relationship. A guideline describes averages and trade-offs across groups of patients. It cannot say which treatment fits your history, your other conditions, or the medicines you already take. Do not stop a sleep medicine on your own because a guideline ranked another treatment higher. If you want to change your plan, bring this post to your visit and decide together.

If you are having thoughts of harming yourself, help is available now: call or text 988, text HOME to 741741 for Crisis Text Line, or call the NAMI Helpline at 1-800-950-6264. This practice is not an emergency service. If someone is in immediate danger, call 911. The crisis page lists more options.